Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Corganics is a private U.S. life sciences and healthcare company focused on clinical-grade cannabinoid products distributed through healthcare professionals. The company markets broad-spectrum, THC-free CBD products and a natural topical pain portfolio aimed at non-opioid symptom management, particularly in pain-related settings. Its offerings emphasize physician-advised formulations, third-party testing, cGMP-compliant manufacturing, and enhanced oral absorption through its Advanced Lipid Technology platform. Corganics appears to operate commercially rather than as a traditional drug-development biotech, with products sold into medical practices across multiple specialties. The company was previously known as MD Farma and now positions itself as a clinically oriented cannabinoid therapeutics brand for provider channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Corganics.